Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05215106 |
|---|---|
| Brief Title: | Short-term Pre-OPerative Durvalumab (MEDI 4736) in Early Small Triple Negative Breast Cancer Patients (POP-Durva) (POP-DURVA) |
| First Submitted : | December 22, 2021 |
| First Submitted that Met QC Criteria : | January 17, 2022 |
| First Posted : | January 31, 2022 |
| Last Update Submitted that Met QC Criteria : | June 2, 2023 |
| Last Update Posted : | June 6, 2023 |